ArticleThrombosis journal2021

Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19.

Fumihiro Ogawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.